Eli Lilly's gene-silencing drug lepodisiran has been shown to reduce lipoprotein(a) levels by more than 90% for at least six months with a single injection in a phase 2 trial, reinforcing its ...

Amgen has reported encouraging mid-stage results for its olpasiran candidate for reducing lipoprotein(a) – a risk factor for atherosclerotic cardiovascular disease – and now plans to move ahead ...

This price reflects trading activity during the overnight session on the Blue Ocean ATS, available 8 PM to 4 AM ET, Sunday through Thursday, when regular markets are closed. ZBRA: Risk or rebound?

Key data is currently not available. Data Disclaimer: The Nasdaq Indices and the Major Indices are delayed at least 1 minute. *Data is provided by Barchart.com. Data reflects weightings calculated at ...

Zebrafish (Danio rerio) is a small freshwater fish that is an extensively studied vertebrate model organism. It can be bred rapidly in large numbers, is amenable to genetics, and has a clear embryo, ...

LPUs grant owners a share in the partnership's income, avoiding double taxation. MLPs distribute available cash to unit holders after deducting maintenance capital. Limited partners only risk losing ...

Abstract: In this paper, a new bio-inspired metaheuristic algorithm called Zebra Optimization Algorithm (ZOA) is developed; its fundamental inspiration is the behavior of zebras in nature. ZOA ...

A diverse local artist is releasing his sophomore LP, THE WORLD IS ALWAYS ENDING SOMETIMES, a genre-exploring project that adds to a body of work that is already hard to identify. Allen Condes’ sound ...

Is MPLX the next big buy? Chart does not reflect overnight price.